AbbVie
ABBV
$250.18
Share price
1.95%
Change (1 day)
8.02%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: C$442.56 Billion
As of April 2025 AbbVie has a market cap of C$442.56 Billion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$442.56 B | -1.96% |
| 2024 | C$451.39 B | 24.39% |
| 2023 | C$362.89 B | -6.43% |
| 2022 | C$387.82 B | 27.13% |
| 2021 | C$305.06 B | 26.47% |
| 2020 | C$241.20 B | 41.04% |
| 2019 | C$171.01 B | -7.91% |
| 2018 | C$185.71 B | -4.33% |
| 2017 | C$194.10 B | 41.94% |
| 2016 | C$136.75 B | 3.37% |
| 2015 | C$132.29 B | 9.47% |
| 2014 | C$120.85 B | 35.43% |
| 2013 | C$89.23 B | 66.27% |
| 2012 | C$53.67 B |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of AbbVie was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | C$178.79 B | -59.60% | 🇺🇸 USA |
 | C$136.48 B | -69.16% | 🇺🇸 USA |
 | C$1.059 T | 139.49% | 🇺🇸 USA |
 | C$209.39 B | -52.69% | 🇺🇸 USA |
 | C$184.98 B | -58.20% | 🇺🇸 USA |
 | C$24.26 B | -94.52% | 🇺🇸 USA |
 | C$104.83 B | -76.31% | 🇬🇧 UK |
 | C$298.95 B | -32.45% | 🇬🇧 UK |
 | C$14.35 B | -96.76% | 🇺🇸 USA |